Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: A Swedish nationwide study

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 2, 2017, Pages 582-588

  Ny, Sofia ^a,b   Löfmark, Sonja ^a   Börjesson, Stefan ^c   Englund, Stina ^c   Ringman, Maj ^a   Bergström, Jakob ^a   Nauclér, Pontus ^b,d   Giske, Christian G ^b,d   Byfors, Sara ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE AMPC; PENICILLIN DERIVATIVE; PENICILLINASE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOODSTREAM INFECTION; COMPARATIVE STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GENETIC CODE; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SANGER SEQUENCING; SWEDEN; TRAFFIC AND TRANSPORT; ADOLESCENT; AGED; BACTEREMIA; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PATHOGENICITY; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CARRIER STATE; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; SWEDEN; YOUNG ADULT;

EID: 85014542935     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw419     Document Type: Article

References (37)

1. Woerther P-L, Burdet C, Chachaty E et al. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013; 26: 744-58.
2. Hassing RJ, Alsma J, Arcilla MS et al. International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review. Euro Surveill 2015; 20; pii=30074.
3. Tumbarello M, Sali M, Trecarichi EM et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 2008; 52: 3244-52.
4. Public Health Agency of Sweden, National Veterinary Institute. 2014 SWEDRES SVARM-Consumption of Antibiotics and Occurrence of Antibiotic Resistance in Sweden.
5. Stromdahl H, Tham J, Melander E et al. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis 2011; 30: 1159-62.
6. Östholm-Balkhed Å, Tärnberg M, NilssonMet al. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother 2013; 9: 2144-53.
7. Sasaki T, Hirai I, Niki M et al. High prevalence of CTX-M β-lactamaseproducing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand. J Antimicrob Chemother 2010; 65: 666-8.
8. Sun Q, Tarnberg M, Zhao L et al. Varying high levels of faecal carriage of extended-spectrum β-lactamase producing Enterobacteriaceae in rural villages in Shandong, China: implications for global health. PLoS ONE 2014; 9: e113121.
9. Picard B, Garcia JS, Gourion S et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999; 67: 546-53.
10. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014; 27: 543-74.
11. Price LB, Johnson JR, Aziz M et al. The epidemic of extendedspectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 2013; 4: e00377-13.
12. Chung HC, Lai CH, Lin JN et al. Bacteremia caused by extendedspectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 2012; 56: 618-22.
13. Peirano G, Pitout JDD. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316-21.
14. Johnson JR, Johnston B, Clabots C et al. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51: 286-94.
15. Mathers AJ, Peirano G, Pitout JDD. Escherichia coli ST131: the quintessential example of an international multiresistant high-risk clone. Adv Appl Microbiol 2015; 90: 109-54.
16. Ranjan A, Shaik S, Hussain A et al. Genomic and functional portrait of a highly virulent, CTX-M-15-producing H30-Rx subclone of Escherichia coli sequence type 131. Antimicrob Agents Chemother 2015; 59: 6087-95.
17. Hussain A, Ranjan A, Nandanwar N et al. Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India. Antimicrob Agents Chemother 2014; 58: 7240-9.
18. Totsika M, Beatson SA, Sarkar S et al. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS ONE 2011; 6: e26578.
19. Johnson JR, Porter SB, Zhanel G et al. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 2012; 80: 1554-62.
20. Johnson JR, Tchesnokova V, Johnston B et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 2013; 207: 919-28.
21. Tängdén T, Cars O, Melhus Å et al. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extendedspectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
22. Rolfhamre P, Jansson A, Arneborn M et al. SmiNet-2: description of an internet-based surveillance system for communicable diseases in Sweden. Euro Surveill 2006; 11: 103-7.
23. Brolund A. Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective. Infect Ecol Epidemiol 2014; 4: 1-9.
24. Clermont O1 BS, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
25. Clermont O, Dhanji H, Upton M et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64: 274-7.
26. Colpan A, Johnston B, Porter S et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 2013; 57: 1256-65.
27. Borjesson S, Egervarn M, Lindblad M et al. Frequent occurrence of extended-spectrum β-lactamase-and transferable AmpC β-lactamaseproducing Escherichia coli on domestic chicken meat in Sweden. Appl Environ Microbiol 2013; 79: 2463-6.
28. Habeeb MA, Haque A, Iversen A et al. Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan. Eur J Clin Microbiol Infect Dis 2014; 33: 399-409.
29. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002; 21: 2409-19.
30. van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw 2011; 45: 1-67.
31. Roderick JA Little, Donald BR. Statistical Analysis with Missing Data, 2nd edition. New York: John Wiley, 2002.
32. Lafolie J, Sauget M, Cabrolier N et al. Detection of Escherichia coli sequence type 131 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: implications for infection control policies? J Hosp Infect 2015; 90: 208-12.
33. Nakamura A, Komatsu M, Kondo A et al. Rapid detection of B2-ST131 clonal group of extended-spectrum β-lactamase-producing Escherichia coli by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry: discovery of a peculiar amino acid substitution in B2-ST131 clonal group. Diagn Microbiol Infect Dis 2015; 83: 237-44.
34. Wang M-C, Tseng C-C, Chen C-Y et al. The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection. Clin Infect Dis 2002; 35: 1161-6.
35. Valenza G, Nickel S, Pfeifer Y et al. Extended-spectrum-β-lactamaseproducing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother 2014; 58: 1228-30.
36. Overdevest I, Willemsen I, Rijnsburger M et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis 2011; 17: 1216-22.
37. Kantele A, Laaveri T, Mero S et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis 2015; 60: 837-46.